Infectious Diseases
C-Reactive Protein (CRP) FIA Rapid Assay Kit
The BeingBio C-Reactive Protein (CRP) Fluorescence Immunoassay (FIA) Test is a rapid and reliable point-of-care diagnostic tool designed to measure CRP levels in human serum, plasma, or whole blood. This easy-to-use lateral flow test provides accurate, quantitative results in just 3 minutes, using the innovative Multi-channels FIA system.
Healthcare professionals can use the BeingBio CRP FIA Test to quickly determine the presence of inflammation. With a convenient cut-off level of 10 mg/L, this test helps identify elevated CRP levels, signaling an inflammatory response.
Important Note: While the BeingBio CRP FIA Test effectively detects inflammation, it does not pinpoint the underlying cause. Healthcare providers will use the test results in conjunction with a patient’s medical history, physical examination, and other diagnostic tests to determine the source and develop an appropriate treatment plan.
COVID-19 Rapid Ag Self-Test Kit (FDA Approved)
$7.99 – $11.99
Rapid Self-Test Kit for SARS-CoV-2 Antigens is an accurate and easy-to-use solution for detecting COVID-19 manufactured by Genabio.
This non-prescription test is designed for self-testing at home with anterior nasal swab specimens. It is authorized for individuals aged 14 years or older, or adult-collected samples from individuals aged 2 years or older within the first 7 days of symptom onset. With improved performance in detecting Omicron variants, this Rapid Self-Test Kit provides reliable results that US FDA authority has approved for EUA.
Each test includes a short nasal swab, buffer tube with drop cap, foil-sealed test cassette, and clear instructions. Results are available within 15 minutes. This test comes in sizes of 1 test/pack and 2 tests/pack, and the compact packaging reduces costs and is more environmentally friendly. Manufactured in ISO13485 accredited Genabio facilities.
Select options
This product has multiple variants. The options may be chosen on the product page
Flu A/B & COVID-19 Multiplex Rapid Test (3-in-1 Home Self-Test)
$14.99 – $21.99
This test is authorized for the qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B protein antigens. This test is authorized for non-prescription home use with self-collected anterior nasal swab specimens from individuals aged 14 years or older, or with adult-collected anterior nasal swab specimens from individuals two (2) years or older.
Stay ahead of the curve and ensure your health with our latest Tyfast Flu A/B & COVID-19 Multiplex Rapid Home Test Kit (OTC options). This state-of-the-art rapid test empowers you to quickly check for both flu (A & B) and COVID-19 infection from the comfort of your home in just 10 minutes. Perfect for anyone experiencing symptoms of respiratory diseases, our kit offers peace of mind with swift and accurate results.
- Enjoy Fast Results: Get clear answers fast, enabling you to take the next steps sooner.
- Multi Target: Taking control of your health has never been easier or more convenient. Get fast, accurate, and reliable results, and stay one step ahead of flu and COVID-19.
- Rely on Precision: Trust in the clinical accuracy that accurately detects flu and COVID-19 antigens, giving you the certainty you need.
- User-Friendly: Our simple, straightforward design makes at-home testing a breeze, no matter where you are.
- Nasal Swab
Select options
This product has multiple variants. The options may be chosen on the product page
Freeze-Dried Multiplex Real Time PCR Kit for High Risk Types 16 and 18 of HPV
$50.00
The BeingBio RealTime High-Risk HPV kit is suitable for in vitro qualitative detection of 14 high-risk types of human papillomavirus (including HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 66) nucleic acid material DNA in female cervical cell samples, and genotyping detection of HPV16 and HPV18 among them.
Select options
This product has multiple variants. The options may be chosen on the product page
Freeze-Dried Multiplex Real Time PCR Kit for HPV High-Risk Gene-type Screen
$50.00
BeingBio Multiplex Real Time PCR Kit for HPV High-Risk Gene-type Screen kit is suitable for the detection of human papillomavirus (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) DNA typing in female cervical exfoliated cells. The kit is used for the auxiliary diagnosis of human papillomavirus infection, and can identify the specific types of human papillomavirus in each group. The test results of the kit are for clinical reference only and should not be used as the sole basis for diagnosis or exclusion.
Select options
This product has multiple variants. The options may be chosen on the product page
Freeze-Dried Multiplex Real Time PCR Kit for Mycoplasma hominis / Mycoplasma genitalium
$50.00
BeingBio Freeze-Dried Multiplex Real Time PCR Kit for Mycoplasma hominis / Mycoplasma genitalium kit was used for qualitative detection of Mycoplasma hominis (MH) and Mycoplasma genitalium (MG) nucleic acid reproductive tract secretions samples. It can be used for aided diagnosis of MH and MG.
Select options
This product has multiple variants. The options may be chosen on the product page
Freeze-Dried Multiplex Real Time PCR Kit for Types 6 and 11 of HPV
$50.00
BeingBio Freeze-Dried Multiplex Real Time PCR Kit for Types 6 and 11 of HPV is intended for use as qualitative detection of Types 6 and 11 of HPV nucleic acid in cervical swab samples of suspected cases of HPV infection, suspected cluster cases, and others for the diagnosis or differential diagnosis of HPV infection.
Select options
This product has multiple variants. The options may be chosen on the product page
Freeze-Dried Multiplex Real-Time PCR Kit for Streptococcus pneumonia / Mycoplasma pneumonia
$50.00
BeingBio Freeze-Dried Multiplex Real Time PCR Kit for Streptococcus pneumonia / mycoplasma pneumonia kit is suitable for qualitative detection of Streptococcus pneumonia (SP) and Mycoplasma Pneumonia (MP) in sputum or throat swabs samples of patients. It can be used for auxiliary diagnosis of mycoplasma pneumonia and streptococcus pneumonia.
Select options
This product has multiple variants. The options may be chosen on the product page
Human Papilloma Virus (HPV) Antigen Rapid Test Kit
$45.99Intended Use
This rapid visual immunoassay developed for the qualitative presumptive detection of HPV 16/18 E6 and E7 oncoproteins in cervical swab specimens from women. It is designed to support the diagnosis of cervical pre-cancer and cancer, offering a valuable ability particularly in low-resource settings with limited access to comprehensive screening methods. By detecting the critical oncoproteins responsible for cervical cell transformation, this test provides a simple, efficient, and cost-effective approach to evaluating HPV oncogenic activity.
Monkeypox Virus Antigen Rapid Test
$89.99INTENDED USE
Monkeypox Virus Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of monkeypox virus antigen in human rash exudates and blood samples.
MATERIALS PROVIDED
• Monkeypox Virus Ag Test
• Instructions Sheet
• Pipette
• Swab
• Treatment tube containing sample treatment solution
• Buffer solution
Monkeypox Virus Fluorescence PCR Kit
$199.99INTENDED USE
Monkeypox Virus IgM/IgG Ab Test is a lateral flow chromatographic immunoassay used for the qualitative detection of monkeypox virus IgM and IgG antibodies in human whole blood/serum/plasma samples.
MATERIALS PROVIDED
• Monkeypox Virus IgM/IgG Test
• Instructions Sheet
• Buffer solution
• Pipette
• Alcohol cotton
• Sterilized lancet
Monkeypox Virus IgM/IgG Antibody Test
$89.99INTENDED USE
Monkeypox Virus IgM/IgG Ab Test is a lateral flow chromatographic immunoassay used for the qualitative detection of monkeypox virus IgM and IgG antibodies in human whole blood/serum/plasma samples.
MATERIALS PROVIDED
• Monkeypox Virus IgM/IgG Test
• Instructions Sheet
• Buffer solution
• Pipette
• Alcohol cotton
• Sterilized lancet
SARS-CoV-2/Flu A/FLu B/RSV/ADV/MP Antigen Rapid Test Kits
$29.991 Test/BoxIntended Use
The visual reading test kit is a rapid, qualitative diagnostic tool designed for the simultaneous detection of antigens from six major respiratory pathogens: SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Adenovirus, and Mycoplasma pneumoniae. This test is intended for use with throat swab specimens collected from individuals exhibiting symptoms of respiratory tract infections, such as cough, fever, sore throat, or difficulty breathing.
The primary purpose of this six-in-one respiratory panel is to provide accurate and timely identification of the causative pathogen responsible for respiratory illnesses. By detecting specific antigens associated with these pathogens, the kit aids in differentiating between viral and bacterial infections, enabling healthcare providers to make informed decisions regarding treatment and infection control measures.
This test is particularly valuable in clinical settings, such as hospitals, outpatient clinics, and emergency departments, where rapid diagnosis is critical for patient management and preventing the spread of infectious diseases. It is also suitable for use in point-of-care (POC) settings, such as your doctor office or at-home testing, offering results within 15–20 minutes without the need for specialized laboratory equipment.
Infectious diseases pose a significant threat to global health. Early detection and accurate diagnosis are crucial for containing outbreaks, guiding treatment decisions, and preventing transmission. Clinical diagnostic testing plays a vital role in managing infectious diseases effectively by identifying causative agents such as bacteria, viruses, parasites, or fungi.
Timely and accurate diagnostic testing not only improves patient outcomes but also informs public health initiatives and targeted interventions. This necessity becomes more apparent during outbreaks or pandemics, like COVID-19, when rapid testing is essential for identifying cases, implementing containment measures, and allocating resources. Diagnostic testing provides reliable data for evidence-based decision-making, crucial for mitigating the impact of infectious diseases on individuals and communities.